Fimasartan/Amlodipine Combination Phase III

PHASE3CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions
Essential Hypertension
Interventions
DRUG

Fimasartan and Amlodipine

DRUG

Fimasartan

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Bundang

Sponsors
All Listed Sponsors
collaborator

Gachon University Gil Medical Center

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Korea University Guro Hospital

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

DongGuk University

OTHER

collaborator

Dong-A University Hospital

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Pusan National University Yangsan Hospital

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Gangnam Severance Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Ulsan University Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Inje University Haeundae Paik Hospital

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Jeju National University Hospital

OTHER

collaborator

Chungnam National University

OTHER

collaborator

Hanyang University Seoul Hospital

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY